FDA approves new HPV cervical cancer test

The test was approved despite objections from some that the screening had not been adequately tested.

Modern Healthcare: FDA Approves First HPV Test For Primary Cervical-Cancer Screening
The first human papillomavirus DNA test to screen women for cervical cancer was approved Thursday by the U.S. Food and Drug Administration. The stand-alone test can be used to assess whether women need to undergo additional testing and their risk of developing cervical cancer in the future (Rice, 4/24).

The New York Times: Alternative to Pap Test Is Approved By F.D.A.
A committee of outside advisers to the F.D.A. unanimously endorsed the Roche test in a meeting last month. But a coalition of 17 consumer, women's and health groups opposed the approval, arguing that the new screening method had not been adequately tested and could upend a practice that has successfully prevented cervical cancer for decades (Pollack, 4/24).

This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

News-Medical.Net provides this medical information service in accordance
with these terms and conditions.
Please note that medical information found
on this website is designed to support, not to replace the relationship
between patient and physician/doctor and the medical advice they may provide.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Find out more here.